Rt. Hiefingerschindlbeck et al., DIFFERENTIATION OF HUMAN PHOSPHOLIPASE-A(2) ISOENZYMES IN SERUM AND OTHER BODY-FLUIDS WITH USE OF MONOCLONAL-ANTIBODIES, European journal of clinical chemistry and clinical biochemistry, 31(4), 1993, pp. 211-215
Elevated phospholipase A2 activities in serum were measured in patient
s suffering from acute pancreatitis or various inflammatory diseases.
The photometric phospholipase A assay of Hoffmann & Neumann (Klin. Woc
henschr. 67 (1989) 106-109) was combined with immunoabsorption by diff
erent monoclonal antibodies directed against pancreatic phospholipase
A2. Pancreatic phospholipase A2 was purified from human duodenal juice
. Monoclonal antibodies were prepared by fusion of spleen cells from i
mmunized mice with P3X63-Ag8-653 myeloma cells. Samples with phospholi
pase A2 activity were incubated in monoclonal antibody-coated microtit
re plates. Phospholipase A2 activities were determined in the monoclon
al antibody-treated samples as well as in control samples. The method
allows the determination of the fraction of human phospholipase A2 iso
enzymes in various biological materials. For pancreatic phospholipase
A2 the specific binding capacity was about 60-80%, the unspecific bind
ing was 5-30%. Practically no crossreactivity was seen with partially
purified serum phospholipase A2, With recombinant platelet phospholipa
se A2, or with the sera of patients with non-pancreatic diseases. In c
onclusion, the present study confirmed the presence of pancreatic phos
pholipase A2 in human duodenal juice and in the ascites of necrotizing
pancreatitis. However, pancreatic isoenzyme was absent in non-pancrea
tic inflammatory diseases. Therefore, elevated phospholipase activitie
s in non-pancreatic inflammatory diseases cannot be attributed to the
pancreas.